CHOP’s groundbreaking expertise in treating children with congenital hyperinsulinism (HI) began more than 50 years ago and draws patients from all over the world.

CHOP researchers will take data gleaned from helping pro athletes avoid head injuries to improve prevention, diagnosis and treatment of concussions in kids.

Two generations of the Parkes family have come to Children’s Hospital of Philadelphia for treatment for hyperinsulinism (HI). They’ve seen and experienced breakthroughs in HI care firsthand.

CHOP patient family credits faith and doctors for recovery and donates $50,000 to Children's Hospital of Philadelphia.

Medical interpreters are key to overcoming obstacles when providing medical care for limited English proficient (LEP) families. Federal law requires providing medical interpreters to LEP families.

Children and teens are at greater risk for suicide now than before COVID-19. Learn how to start the conversation about mental health with your child.

The center offers evaluation, diagnosis, treatment, and follow-up care for children with this life-threatening condition.

Dr. Campbell's innovative thought-leadership and inventions changed the world’s approach to caring for children with complex and life-threatening spine and chest wall deformities. Join us in honoring his remarkable career.

A new study found that otherwise mild changes in the DNA in mitochondria combine with familiar nuclear DNA to dramatically affect heart disease in animals.

The new research platform will make large-scale data on childhood cancer and birth defects available to researchers, clinicians and patients within a cloud-based environment.